•
Jun 30, 2021

Pliant Therapeutics Q2 2021 Earnings Report

Total Revenue
$1.79M
Previous year: $3.6M
-50.3%
EPS
-$0.64
Previous year: -$1.39
-54.0%
Gross Profit
$1.79M
Previous year: $3.6M
-50.3%
Cash and Equivalents
$35.2M
Previous year: $178M
-80.3%
Free Cash Flow
-$20M
Previous year: $7.49M
-367.7%
Total Assets
$256M
Previous year: $329M
-22.2%

Pliant Therapeutics

Pliant Therapeutics